Finance News World

Dr. Watson CBD signs $5.5m deal for CBD products in Japan

 Breaking News
  • No posts were found

Dr. Watson CBD signs $5.5m deal for CBD products in Japan

February 03
23:16 2020
Dr. Watson CBD signs $5.5m deal for CBD products in Japan

Global hemp and CBD company Dr. Watson CBD recently announced signing a deal worth $5.5m for CBD products in Japan. This deal marks a milestone for the innovative CBD company, and is a testament to the quality of products produced for sale online and in store.

The Global CBD Market

Within the course of the last decade, the global CBD market has grown to astonishing heights, leaving many market analysts in awe. Relaxed regulations, coupled with consumer demand and multiple studies supporting its use for health and well-being, demand for the supplement is expected to go in one direction: up. In fact, some projections put the global CBD and hemp market at $20 billion by the year 2024.

The Japanese CBD and Hemp Market

According to Dr. Watson, the Japanese market is notoriously difficult to enter for CBD companies. Stringent regulations and compliance are strong barriers to entry for many companies seeking to expand distribution and sales to the region. Yet with a GDP of around $5 trillion, the market is one that is coveted by companies across a broad range of industries.

Hemp has always been a significant part of traditional Japanese culture, making the market attractive for CBD companies seeking to provide the Japanese population with high-quality hemp and CBD products. As the demand for CBD continues to rise, the supplement is quickly taking center stage as a stable in the health and wellness market both in Japan and internationally.

In a statement obtained from Dr. Watson (CEO), he noted, that “We are extremely excited about the Japanese market. It is one of the best consumer markets for high-quality goods in the world. The Japanese respect both quality and authenticity and Dr Watson CBD products offer both of those things”.

About Dr Watson CBD

DR WATSON CBD is a global CBD and hemp company based in London and backed by Chief Scientist Dr. Richard Watson, Ph.D. The brand is the exclusive producer of “Dr. Watson CBD” product line, and is on a mission to lead the industry in quality, consistency, and traceability from seed to shelf.


Transparency – Safety, purity, and potency are hallmarks of their lineup of CBD products. Each batch of ingredients is tested to ensure customers get what is promised on the label. As a testament to their focus on transparency, records of each lab test is made available for customers to verify on


Since inception Dr. Watson CBD has worked tirelessly to earn the trust and respect of the industry and its customers, striving to produce highly effective products that exceed expectations.


From “seed to shelf”, the company tracks every ingredient, how its made and how it’s cultivated or processed. This level of control provides consistency and reliability unparalleled in the industry.

About Dr Watson

Dr. Richard Watson is a New Zealand-born American biotechnology scientist and agricultural researcher. For the past two decades, Dr. Watson has concentrated his work on the research, development and operation of innovative and sustainable agricultural methods. He perfected these methodologies in the Georgia Coastal Plain, USA where he owns several thousand acres of irrigated farmland.

Those interested in learning more about Dr Watson CBD are encouraged to reach out via their official website or by way of the media contact information below.

Media Contact
Company Name: Breathe International Ltd
Contact Person: Sam Watson
Email: Send Email
Phone: 078774697588
Address:227 Shepherd\’s Bush Road
City: Hammersmith
State: London
Country: United Kingdom